![Heather Raymon](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Heather Raymon
Corporate Officer/Principal at Artiva Biotherapeutics, Inc.
Heather Raymon active positions
Companies | Position | Start | End |
---|---|---|---|
Artiva Biotherapeutics, Inc.
![]() Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 2020-09-30 | - |
Career history of Heather Raymon
Former positions of Heather Raymon
Companies | Position | Start | End |
---|---|---|---|
CELGENE | Corporate Officer/Principal | - | - |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - | - |
Training of Heather Raymon
State University of New York at Albany | Undergraduate Degree |
University of California, Irvine | Doctorate Degree |
Statistics
International
United States | 6 |
Operational
Corporate Officer/Principal | 3 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Private companies | 2 |
---|---|
Artiva Biotherapeutics, Inc.
![]() Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Health Technology |
Celgene Corp.
![]() Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Stock Market
- Insiders
- Heather Raymon
- Experience